Cowley et al reported that the p-ETS1 is the inhibitory form of ETS1 activity [30], therefore, we consider that phosphorylation modification is critical for ETS1 function and its activity in HCC samples. The gene discussed is ETS1; the disease is hepatocellular carcinoma.